Who are we? Information request Case studies News & Events Careers Investor Base of knowledge Belgium Instrument The tests Connectivity Customer experiences Customer service Rt-PCR solutions Offer new perspectives to Biology Through the LumiraDx Platform * focused on Relocated Biology and Decentralized Laboratory Performance comparable to that of laboratory automatons The automaton uses measurement methods similar to those of laboratory analyzers, which makes it possible to offer performance comparable to that of a laboratory and quality results in real time as close as possible to patients Wide range of tests Taking into account budgetary constraints The LumiraDx Platform is a new generation automaton which combines a small portable instrument and a wide range of microfluidic cards. Without forgetting connectivity solutions compatible with the IT systems of hospitals and healthcare systems. Latest LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics Read more Résultats à portée de main Résultats comparables à ceux d’un laboratoire en quelques minutes à partir d’un petit échantillon DÉCOUVRIR L’INSTRUMENT Analyse au plus près des patients La LumiraDx Platform permet actuellement l’analyse des antigène et anticorps du SARS-CoV-2, des D-dimères et de l’INR. Le panel de test en développement comporte plus de 30 paramètres utilisant divers types d'analyses, notamment des tests enzymatiques, immunologiques, moléculaires et d’électrolytes. Le tout réalisé sur un seul appareil facile à utiliser. DÉCOUVRIR LA GAMME DE TESTS SARS CoV-2 Ag SARS-CoV-2 Ag Pool Test SARS CoV-2 Ab D-Dimer INR Connecté Notre technologie de pointe basée sur le cloud et l’intégration aux systèmes informatiques de laboratoires permet aux professionnels de la santé d’obtenir facilement des rapports, des analyses et de l'aide à la décision. DÉCOUVRIR LA CONNECTIVITÉ La LumiraDx Platform est conçue pour être abordable et facile à utilisée dans le cadre des soins de proximité Laboratoires Service des urgences Soins primaires Clinique de soins Pharmacie CONSULTER TOUTES LES ACTUALITÉS LumiraDx receives approval for its COVID-19 Antigen Test for use in India Lire la suite LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics Lire la suite PLOS Medicine publishes systematic review and meta-analysis of more than 60 SARS- CoV-2 antigen tests: Ranks LumiraDx’s SARS-CoV-2 Ag Test as most sensitive and accurate Lire la suite DEMANDER DES RENSEIGNEMENTS MAINTENANT *LumiraDx Platform - Plateforme LumiraDx; LumiraDx Instrument – Automate; LumiraDx SARS-CoV-2 Ag Test - Test COVID-19 Ag Antigénique; LumiraDx SARS-CoV-2 Ag Pool Test - COVID-19 Test groupé SARS-CoV-2 Ag; LumiraDx SARS-CoV-2 Ab Test - Test COVID-19 Ab Anticorps; LumiraDx INR Test - Test INR; Lumiradx D-Dimer Test - Test D-Dimère; RNA STAR Complete - PCR RNA STAR COMPLETE COVID-19; RNA STAR COVID-19 - PCR RNA STAR COVID-19; LumiraDx Barcode Scanner - Lecteur code barre; Lumiradx Printer – Imprimante; Small in one – Tout-en-un. Want to be kept informed of the latest LumiraDx developments? Une meilleure santé Participer à l’amélioration de la prise en charge des patients, de la communauté et la société en général. Who are we? Information request Case studies News & Events Careers Investor Instrument The tests Connectivity Customer experiences Customer service Rt-PCR solutions Legal information Terms of use CGV Privacy Policy Guide to good conduct Report on equal pay for men and women Modern slavery Intellectual property EULA Care Solutions UK Headquarters LumiraDx Limited 3 More London Riverside London, SE1 2AQ United Kingdom Company Number: 09206123 Branch LumiraDx Benelux BV Looskade 20 6041 LE Roermond Facebook LinkedIn Twitter © 2021 LumiraDx. All rights reserved, worldwide. Registration Number: 09206123. About cookies in use on this site Our site uses cookies to personalize and improve your comfort of use. See our Privacy Statement to learn more or to manage your personal preferences in our Accept Cookies tool . By using our site, you agree to the use of cookies. Accept Managing cookies